BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sala C, Benjak A, Goletti D, Banu S, Mazza-Stadler J, Jaton K, Busso P, Remm S, Leleu M, Rougemont J, Palmieri F, Cuzzi G, Butera O, Vanini V, Kabir S, Rahman SMM, Nicod L, Cole ST. Multicenter analysis of sputum microbiota in tuberculosis patients. PLoS One 2020;15:e0240250. [PMID: 33044973 DOI: 10.1371/journal.pone.0240250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Barbosa-amezcua M, Galeana-cadena D, Alvarado-peña N, Silva-herzog E. The Microbiome as Part of the Contemporary View of Tuberculosis Disease. Pathogens 2022;11:584. [DOI: 10.3390/pathogens11050584] [Reference Citation Analysis]
2 Xiao G, Cai Z, Guo Q, Ye T, Tang Y, Guan P, Zhang J, Ou M, Fu X, Ren L, Yu M, Wang Z, Liu L, Yang L, Zhang G. Insights into the Unique Lung Microbiota Profile of Pulmonary Tuberculosis Patients Using Metagenomic Next-Generation Sequencing. Microbiol Spectr 2022;10:e0190121. [PMID: 35196800 DOI: 10.1128/spectrum.01901-21] [Reference Citation Analysis]
3 Lai RPJ, Cortes T, Marais S, Rockwood N, Burke ML, Garza-Garcia A, Horswell S, Sesay AK, O'Garra A, Young DB, Wilkinson RJ. Transcriptomic Characterization of Tuberculous Sputum Reveals a Host Warburg Effect and Microbial Cholesterol Catabolism. mBio 2021;12:e0176621. [PMID: 34872348 DOI: 10.1128/mBio.01766-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ticlla MR, Hella J, Hiza H, Sasamalo M, Mhimbira F, Rutaihwa LK, Droz S, Schaller S, Reither K, Hilty M, Comas I, Beisel C, Schmid CD, Fenner L, Gagneux S. The Sputum Microbiome in Pulmonary Tuberculosis and Its Association With Disease Manifestations: A Cross-Sectional Study. Front Microbiol 2021;12:633396. [PMID: 34489876 DOI: 10.3389/fmicb.2021.633396] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Sekyere JO, Maningi NE, Matukane SR, Mbelle NM, Fourie PB. An Oxford Nanopore-based Characterisation of Sputum Microbiota Dysbiosis in Patients with Tuberculosis: from baseline to 7 days after Antibiotic Treatment.. [DOI: 10.1101/2021.06.24.21259332] [Reference Citation Analysis]
6 HaileMariam M, Yu Y, Singh H, Teklu T, Wondale B, Worku A, Zewude A, Mounaud S, Tsitrin T, Legesse M, Gobena A, Pieper R. Protein and Microbial Biomarkers in Sputum Discern Acute and Latent Tuberculosis in Investigation of Pastoral Ethiopian Cohort. Front Cell Infect Microbiol 2021;11:595554. [PMID: 34150670 DOI: 10.3389/fcimb.2021.595554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]